|
3Q0H
Structure of T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT)
Deposited 2010-12-15
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
22–137(116 aa)
Fragment:Ig-like V-type domain residues 22-137
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;298 K;1.3M Ammonium Sulfate, 0.1M MES pH 6.0, Vapor diffusion, Sitting drop, temperature 298K
|
Resolution 1.70 Å
R-free 0.237
|
|
3Q0H
Structure of T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT)
Deposited 2010-12-15
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
22–137(116 aa)
Fragment:Ig-like V-type domain residues 22-137
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;298 K;1.3M Ammonium Sulfate, 0.1M MES pH 6.0, Vapor diffusion, Sitting drop, temperature 298K
|
Resolution 1.70 Å
R-free 0.237
|
|
3RQ3
Structure of T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT) in hexagonal crystal form
Deposited 2011-04-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
22–137(116 aa)
Fragment:UNP residues 22-137
Chain B
22–137(116 aa)
Fragment:UNP residues 22-137
|
Not recorded
|
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;298 K;1.0M Ammonium Sulfate, 0.1M BIS-TRIS pH 5.5, 1% PEG3350, Vapor diffusion, Sitting drop, temperature 298K
|
Resolution 2.70 Å
R-free 0.253
|
|
3UCR
Crystal structure of the immunoreceptor TIGIT IgV domain
Deposited 2011-10-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
23–128(106 aa)
Fragment:UNP residues 23-128
Chain C
23–128(106 aa)
Fragment:UNP residues 23-128
|
Not recorded
|
CL CHLORIDE ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;1.5 M (NH4)2SO4 and 0.1M HEPES pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.63 Å
R-free 0.274
|
|
3UCR
Crystal structure of the immunoreceptor TIGIT IgV domain
Deposited 2011-10-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain B
23–128(106 aa)
Fragment:UNP residues 23-128
Chain D
23–128(106 aa)
Fragment:UNP residues 23-128
|
Not recorded
|
CL CHLORIDE ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;1.5 M (NH4)2SO4 and 0.1M HEPES pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.63 Å
R-free 0.274
|
|
3UDW
Crystal structure of the immunoreceptor TIGIT in complex with Poliovirus receptor (PVR/CD155/necl-5) D1 domain
Deposited 2011-10-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
20–128(109 aa)
Fragment:TIGIT, UNP residues 20-128
Chain B
20–128(109 aa)
Fragment:TIGIT, UNP residues 20-128
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;298 K;0.1 M Ammonium acetate
0.1 M Bis-Tris pH 5.5
17% PEG 10000, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.90 Å
R-free 0.287
|
|
5V52
Structure of TIGIT bound to nectin-2 (CD112)
Deposited 2017-03-13
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
22–128(107 aa)
|
Not recorded
|
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;1.3 M Lithium Sulfate
0.1M Tris ph7
|
Resolution 3.10 Å
R-free 0.236
|
|
5V52
Structure of TIGIT bound to nectin-2 (CD112)
Deposited 2017-03-13
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
22–128(107 aa)
|
Not recorded
|
SO4 SULFATE ION × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;1.3 M Lithium Sulfate
0.1M Tris ph7
|
Resolution 3.10 Å
R-free 0.236
|
|
7VYT
Crystal structure of human TIGIT(23-129) in complex with the scFv fragment of anti-TIGIT antibody MG1131
Deposited 2021-11-15
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
23–129(107 aa)
|
Not recorded
|
FLC CITRATE ANION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;200mM ammonium citrate, 20% (v/v) polyethylene glycol 3350
|
Resolution 1.53 Å
R-free 0.219
|
|
7VYT
Crystal structure of human TIGIT(23-129) in complex with the scFv fragment of anti-TIGIT antibody MG1131
Deposited 2021-11-15
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain T
23–129(107 aa)
|
Not recorded
|
FLC CITRATE ANION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293.15 K;200mM ammonium citrate, 20% (v/v) polyethylene glycol 3350
|
Resolution 1.53 Å
R-free 0.219
|
|
8JEL
Crystal structure of TIGIT in complexed with Ociperlimab, crystal form I
Deposited 2023-05-16
|
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain J
22–128(107 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M citric acid pH 4.6, 1 M lithium chloride, 7% PEG6000
|
Resolution 2.45 Å
R-free 0.249
|
|
8JEL
Crystal structure of TIGIT in complexed with Ociperlimab, crystal form I
Deposited 2023-05-16
|
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain E
22–128(107 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M citric acid pH 4.6, 1 M lithium chloride, 7% PEG6000
|
Resolution 2.45 Å
R-free 0.249
|
|
8JEL
Crystal structure of TIGIT in complexed with Ociperlimab, crystal form I
Deposited 2023-05-16
|
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain H
22–128(107 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M citric acid pH 4.6, 1 M lithium chloride, 7% PEG6000
|
Resolution 2.45 Å
R-free 0.249
|
|
8JEL
Crystal structure of TIGIT in complexed with Ociperlimab, crystal form I
Deposited 2023-05-16
|
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain L
22–128(107 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M citric acid pH 4.6, 1 M lithium chloride, 7% PEG6000
|
Resolution 2.45 Å
R-free 0.249
|
|
8JEO
Crystal structure of TIGIT in complexed with Tiragolumab
Deposited 2023-05-16
|
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
22–128(107 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M ammonium citrate tribasic pH 7.4, 14% PEG 3350
|
Resolution 2.06 Å
R-free 0.205
|
|
8JEO
Crystal structure of TIGIT in complexed with Tiragolumab
Deposited 2023-05-16
|
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain D
22–128(107 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M ammonium citrate tribasic pH 7.4, 14% PEG 3350
|
Resolution 2.06 Å
R-free 0.205
|
|
8SZY
Crystal Structure of Heterotrimeric Anti-TIGIT Fabs in complex with human TIGIT
Deposited 2023-05-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain T
23–128(106 aa)
|
Mutation:C69S
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;300 K;0.2 M sodium phosphate monobasic monohydrate, 20% w/v Polyethylene glycol 1,000
|
Resolution 2.31 Å
R-free 0.269
|
|
8SZY
Crystal Structure of Heterotrimeric Anti-TIGIT Fabs in complex with human TIGIT
Deposited 2023-05-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain U
23–128(106 aa)
|
Mutation:C69S
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;300 K;0.2 M sodium phosphate monobasic monohydrate, 20% w/v Polyethylene glycol 1,000
|
Resolution 2.31 Å
R-free 0.269
|
|
8VTD
Co-structure of the Fab of the anti-TIGIT Vibostolimab antibody with its antigen
Deposited 2024-01-26
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
22–137(116 aa)
|
Not recorded
|
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;300 K;16% w/v PEG 20K
|
Resolution 1.23 Å
R-free 0.204
|
|
8VTE
Co-structure of the Fab of the anti-TIGIT Vibostolimab antibody with its antigen
Deposited 2024-01-26
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain E
22–137(116 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;300 K;0.02M D-Glucose; 0.02M D-Mannose; 0.02M D-Galactose; 0.02M L-Fucose; 0.02M D-Xylose; 0.02M N-Acetyl-D-Glucosamine; 0.1M Imidazole, 0.1M MES; 20%v/v Glycerol; 10% PEG4K
|
Resolution 2.29 Å
R-free 0.268
|
|
8VTE
Co-structure of the Fab of the anti-TIGIT Vibostolimab antibody with its antigen
Deposited 2024-01-26
|
Different construct
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain F
22–137(116 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;300 K;0.02M D-Glucose; 0.02M D-Mannose; 0.02M D-Galactose; 0.02M L-Fucose; 0.02M D-Xylose; 0.02M N-Acetyl-D-Glucosamine; 0.1M Imidazole, 0.1M MES; 20%v/v Glycerol; 10% PEG4K
|
Resolution 2.29 Å
R-free 0.268
|